Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) Enterprise Value (2020 - 2025)

Sotera Health has reported Enterprise Value over the past 6 years, most recently at -$346.5 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$346.5 million for Q4 2025, down 24.24% from a year ago — trailing twelve months through Dec 2025 was -$346.5 million (down 24.24% YoY), and the annual figure for FY2025 was -$346.5 million, down 24.24%.
  • Enterprise Value for Q4 2025 was -$346.5 million at Sotera Health, down from -$301.0 million in the prior quarter.
  • Over the last five years, Enterprise Value for SHC hit a ceiling of -$105.5 million in Q1 2021 and a floor of -$660.2 million in Q1 2023.
  • Median Enterprise Value over the past 5 years was -$266.7 million (2023), compared with a mean of -$258.9 million.
  • Biggest five-year swings in Enterprise Value: tumbled 443.6% in 2023 and later skyrocketed 60.19% in 2024.
  • Sotera Health's Enterprise Value stood at -$106.9 million in 2021, then crashed by 270.63% to -$396.3 million in 2022, then grew by 23.88% to -$301.7 million in 2023, then increased by 7.55% to -$278.9 million in 2024, then decreased by 24.24% to -$346.5 million in 2025.
  • The last three reported values for Enterprise Value were -$346.5 million (Q4 2025), -$301.0 million (Q3 2025), and -$334.3 million (Q2 2025) per Business Quant data.